Sector Update: Biotech Stocks Getting Injection of Buying Interest

By
A A A
Share |

The S&P Biotech Select Index was showing some nice gains in midday trading, up 1.6% at $3,138.40. The Index is working to recover from recent selling - on November 7 the index stood at $2,954. However, year-to-date the SPSIBI is holding on to gains of 38.1%.

Biotech stocks higher today include OncoGenex Pharma ( OGXI ) up 8% following yesterday's update on their Phase 3 SYNERGY trial which, the company notes, is continuing as planned. In addition, Teva Pharma ( TEVA ) up near 4% as it was upgraded to Positive from Neutral at Susquehanna research firm. Also, Avanir Pharma ( AVNR ) up near 4%, ACADIA Pharma ( ACAD ) up 2.9%, and XenoPort ( XNPT ) up 3.2%.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: ACAD , AVNR , OGXI , TEVA , XNPT

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

89,970,926
  • $16.15 ▲ 0.12%
77,131,582
  • $58.94 ▼ 1.31%
67,336,935
  • $26.56 ▲ 1.68%
48,814,124
  • $86.20 ▲ 0.02%
47,526,126
  • $23.21 ▲ 0.78%
44,660,424
  • $23.91 ▲ 6.36%
38,799,699
  • $4.289 ▲ 4.36%
36,199,890
  • $40.01 ▼ 0.97%
As of 4/17/2014, 04:07 PM